Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipilimumab in Advanced Ocular Melanoma
NCT01355120Phase 2Completed
- Start
- Oct 2011
- Primary completion
- Sep 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ipilimumab in Ocular melanoma (OM). Started Oct 2011; status: completed.
02
Drugs
ipilimumab
03
Conditions
Ocular melanoma (OM)
Beyond the preview
Go deeper on NCT01355120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01355120.